IW 374

June 10, 2026 Viktor Zarev 0 min read
  1. AMA swears in new president.
  2. Don’t call physicians “providers”.
  3. AMA urges exemptions in Medicaid work requirements.
  4. House moves toward blocking Medicare AI prior authorizations.
  5. Nearly 600 confirmed Ebola cases in Congo.
  6. Three ways GLP-1s are getting better.
  7. OB-GYN group recommends vaccines for the first time.
  8. Debate over drinking study spirals into politics.
  9. UPMC eliminates 500 positions.
  10. Planned Parenthood clinics close amid funding restrictions.
Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Cardiology July 27, 2026

The Career Perceptions of Heart Failure Cardiology July 27, 2026

Picture this – you graduate medical school (not easy), you do a three-year internal medicine residency, then a three-year general cardiology fellowship, and another year of fellowship, but you’re paid less than your peers in other subspecialties – congrats, you’re an advanced heart failure cardiologist (AHFTC).

Cardiology Business July 23, 2026

The Cost of Cardiology is Driven by Insurers July 23, 2026

New price transparency data reveals how wildly insurance payments, reimbursements, and facility fees for cardiology swing across insurers and states, which underscores the complexity of U.S. healthcare costs.

Cardiology Pharmaceuticals July 20, 2026

An Oral PCSK9i and What it Means for Merck July 20, 2026

PCSK9 inhibitors are some of the most effective LDL-lowering drugs out there, but they’ve all required injection, and some even refrigeration. That just changed, however, with the FDA’s approval of Merck's Lipfendra (enlicitide), the first ever oral PCSK9i.